Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-17

Clinical Trial Update: Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

View source ↗

Summary

A completed study evaluating the efficacy and tolerability of Micardis (telmisartan) and MicardisPlus (telmisartan/hydrochlorothiazide) under usual daily-practi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micardis (telmisartan)
  • MicardisPlus (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED